|
PARIS, April 14, 2026 /PRNewswire/ -- For its 10th anniversary edition, VivaTech returns from June 17 to 20, 2026 at the Porte de Versailles and announces a scale-up. Having become, over ten years, a major European platform for meetings between startups, large corporations, investors and decision-makers, the event boasts 300% audience growth, rising from 45,000 to more than 180,000 visitors in 2025 (171 countries), with startups tripling and investors multiplying twelvefold.
In 2026, VivaTech takes over Hall 7 across three floors, with +30% exhibition space, doubled seating capacity, 15,000 startups, more than 1,500 demonstrations, 4,000+ business and networking meetings, and an "Investors Office Hours" scheme to accelerate connections between founders and international investors. The 2026 edition will focus on the major technological and geopolitical challenges of the next ten years, at a time when AI is establishing itself as a driver of productivity and organizational transformation.
The programme for this new edition is structured around four central themes: "AI & Productivity", "Cybersecurity & Defense", "Greentech & Energy" and "Deeptech". Several announcements will be made as world premieres, including innovations in brain-computer interfaces, exoskeletons, conversational agents, automated vulnerability detection, energy transition solutions, as well as quantum, space and extended reality technologies.
VivaTech also highlights its European dimension, with Germany designated as "Country of the Year 2026", featuring the largest delegation in the show's history (800 m² stand, 200 startups, numerous federal and regional partners, 14 Länder and 12 governmental entities), sending a strong signal in favour of European sovereignty and technological leadership.
This 10th edition also aims to broaden its impact with the general public. For the first time, VivaTech will take to the Champs-Élysées on Sunday, June 14th, with a free and immersive day centred on everyday tech (AI, robots, mobility, climate, health...). On June 20th, the VivaTech Festival will open tech up to 18-35 year-olds through AI & society content, the creator economy, the talents of tomorrow, and a Careers Festival.
Renowned speakers from startups, large corporations and institutions will also be in attendance, confirming the ambition to make this 10th edition a global unmissable event at the crossroads of innovation, business and key debates on the future of technology.
CONTACT: press@vivatechnology.com
PARIS, April 14, 2026 /PRNewswire/ -- For its 10th anniversary edition, VivaTech returns from June 17 to 20, 2026 at the Porte de Versailles and announces a scale-up. Having become, over ten years, a major European platform for meetings between startups, large corporations, investors and decision-makers, the event boasts 300% audience growth, rising from 45,000 to more than 180,000 visitors in 2025 (171 countries), with startups tripling and investors multiplying twelvefold.
In 2026, VivaTech takes over Hall 7 across three floors, with +30% exhibition space, doubled seating capacity, 15,000 startups, more than 1,500 demonstrations, 4,000+ business and networking meetings, and an "Investors Office Hours" scheme to accelerate connections between founders and international investors. The 2026 edition will focus on the major technological and geopolitical challenges of the next ten years, at a time when AI is establishing itself as a driver of productivity and organizational transformation.
The programme for this new edition is structured around four central themes: "AI & Productivity", "Cybersecurity & Defense", "Greentech & Energy" and "Deeptech". Several announcements will be made as world premieres, including innovations in brain-computer interfaces, exoskeletons, conversational agents, automated vulnerability detection, energy transition solutions, as well as quantum, space and extended reality technologies.
VivaTech also highlights its European dimension, with Germany designated as "Country of the Year 2026", featuring the largest delegation in the show's history (800 m² stand, 200 startups, numerous federal and regional partners, 14 Länder and 12 governmental entities), sending a strong signal in favour of European sovereignty and technological leadership.
This 10th edition also aims to broaden its impact with the general public. For the first time, VivaTech will take to the Champs-Élysées on Sunday, June 14th, with a free and immersive day centred on everyday tech (AI, robots, mobility, climate, health...). On June 20th, the VivaTech Festival will open tech up to 18-35 year-olds through AI & society content, the creator economy, the talents of tomorrow, and a Careers Festival.
Renowned speakers from startups, large corporations and institutions will also be in attendance, confirming the ambition to make this 10th edition a global unmissable event at the crossroads of innovation, business and key debates on the future of technology.
CONTACT: press@vivatechnology.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
VIVATECH TAKES IT TO THE NEXT LEVEL FOR ITS 10TH ANNIVERSARY
BARCELONA, Spain, April 14, 2026 /PRNewswire/ -- TCI Biotech, the global CDMO+ leader in health and wellness innovation, will return to Vitafoods Europe 2026 at booth 3F40, Fira Barcelona Gran Via, armed with five bold challenges to the industry's most stubborn pain points.
Building on 46 years of scientific leadership and the momentum of last year's rebranded CDMO vision, TCI arrives in Barcelona not just to showcase products, but to reframe conversations. This year, the company is doubling down on technical breakthroughs, introducing doubleNUTRI ZerO2™—a new oxygen-free preservation technology designed to ensure advanced stability and prevent the degradation of actives that often plagues standard formulations.
Five Provocations. Five Solutions.
TCI's booth experience is organized around five themed touchpoints, each designed to challenge conventional thinking and present a proven TCI alternative.
SCIENCE — Integrated Technologies. Claimable Products.
The market is flooded with "me-too" products that offer surface-level benefits. TCI's proprietary platforms are engineered differently, enabling partners to dominate multiple categories with a single SKU. An example of this innovation is the recently announced SugarLock™. This high-performance peanut skin extract provides advanced blood glucose support, having demonstrated a ~7.4% improvement in fasting blood glucose among clinical trial subjects with elevated baseline values.*[1] By turning complex molecular science into proven, claimable results, SugarLock™ allows brands to lead the metabolic health category with total scientific confidence.
STABILITY — 730 Days. Zero Loss.
Still failing the 24-month stability test? The industry's instinct is to keep reformulating. TCI's answer is to stop guessing and start launching. With real-time stability data on file and proprietary formulation technologies proven to deliver zero vitamin loss over a full 730-day window, TCI partners skip the cycle of costly reformulation and reach shelves with confidence[2].
BIOAVAILABILITY — 200% Absorption.
Science That Sells. "High Dosage" was yesterday's marketing. Today's winning brands lead with "High Absorption." TCI's exclusive doubleNUTRI™ liposomal technology—producing particles at 1–3µm (smaller than red blood cells)—delivers the clinical proof to back it up. With up to 200% enhanced absorption versus standard formats, TCI's bioavailability platform gives brand partners a hook that is as compelling on the shelf as it is in the lab[3].
PROBIOTICS — Cut the Cold Chain. Keep the Benefits.
Cold-chain logistics are quietly destroying probiotic margins. TCI's room-temperature stable probiotic technology keeps strains viable without refrigeration for up to two years. For brands ready to rethink distribution economics while supporting full clinical potency, TCI's probiotic solutions represent one of the most commercially transformative advances in the category.
FORMAT — 10 Formats. One Solution.
The pill isn't going anywhere, but the brands winning globally are those that meet consumers in new forms. From jelly sachets and liquid sachets to powders and beyond, TCI offers over ten delivery formats under one roof, with the formulation expertise to match the right format to the right market.
For more information, please visit https://www.tci-bio.com/.
About TCI Biotech
TCI Biotech (TCI Co., Ltd.) is a global leader in CDMO+ services, specializing in the research, development, and manufacturing of functional foods and skincare. With 46 years of scientific excellence and operations spanning Asia, the Americas, and Europe, TCI delivers high-quality, clinically backed products that empower brand partners worldwide to innovate faster and lead with confidence.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
| [1] Lin, Y.; et al. Evaluation Effects of peanut skin extract on blood glucose regulation and body fat reduction. Journal of Biobased Materials and Bioenergy. 2017;11(3), 242–247. [2] Results based on TCI internal testings. [3] Wen, C. J.; et al. Double Nutri (Liposomal Encapsulation) Enhances Bioavailability of Vitamin C and Extends Its Half-Life in Plasma. Journal of Biomedical Nanotechnology. 2022;18(3), 922–927. |
[1] Lin, Y.; et al. Evaluation Effects of peanut skin extract on blood glucose regulation and body fat reduction. Journal of Biobased Materials and Bioenergy. 2017;11(3), 242–247.
[2] Results based on TCI internal testings.
[3] Wen, C. J.; et al. Double Nutri (Liposomal Encapsulation) Enhances Bioavailability of Vitamin C and Extends Its Half-Life in Plasma. Journal of Biomedical Nanotechnology. 2022;18(3), 922–927.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
TCI Biotech Returns to Vitafoods Europe 2026 with Five Provocations for the Nutraceutical Industry and a Glimpse of the Future
